News
Academy
Editorial PodcastsEditorial VideosProfiles in Medicine
Conference CoverageConference Listing
Pharmaceutical Executive
Partner Perspectives
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Subscribe
Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
Spotlight -
  • Pharmaceutical Executive APEX Awards
  • Latest Executive Roundtables
  • Asembia 2025
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Academy
    • Partner Perspectives
    • Subscribe
Advertisement

Popular Flu Vaccine Educational Campaign Ending at CDC

February 24, 2025
By Mike Hollan
News
Article

Anonymous reports claim the decision came from new leadership at HHS.

Stock.adobe.com

Stock.adobe.com

Unconfirmed reports suggest that a popular flu vaccine educational campaign has come to an end.

NPR reports that it has spoken with two anonymous sources at the CDC who claim that the agency has been advised to end the Wild to Mild campaign.1 According to the sources, paid media for the campaign ended on Wednesday and the campaign’s website was temporarily taken down.

As of Friday morning, the website is up and active. However, the site shows details from the campaign from its initial launch in 2023, as opposed to the updated 2024 which had reportedly been active up until Wednesday.

Campaign imagery would show two different animals, such as a lion and a house cat. The messaging said that getting a flu was like reducing the severity of the illness from a lion to a house cat (or other similar animal comparisons).

According to NPR’s report, leadership at the National Center for Immunization and Respiratory Diseases reviewed the campaign and made the decision not to continue. The report does not a cite a specific reason for the campaign’s conclusion.

The NPR report notes that the decision was made during Robert F. Kennedy Jr.’s first full week as the head of HHS. Kennedy has previously criticized aspects of vaccines and has been described as being anti-vax. However, Kennedy denies being anti-vax. During his confirmation hearings, he stated that he would make decisions based on science and research.

In a statement to NPR, HHS spokesperson Andrew Nixon said, “Unfortunately, officials inside the CDC who are averse to Secretary Kennedy and President Trump's agenda seem to be intentionally falsifying and misrepresenting guidance they receive."

The current Wild to Mild website (dated September, 2023),2 explains, “The Wild to Mild campaign is based on consumer research showing that many people believe flu vaccination doesn't work because of first or second-hand experience where vaccination may not have prevented illness. Flu vaccine varies in how well it works. For many years, CDC measured vaccine effectiveness according to how well it prevented illness that required medical treatment. In recent years, however, CDC has expanded its vaccine effectiveness work to include looking at how well flu vaccine works at preventing serious outcomes, like emergency department visits and hospitalizations. This work has contributed to a strong and growing body of evidence that flu vaccination reduces the risk of serious outcomes in people who get vaccinated but still get sick. The Wild to Mild campaign visually shows how flu vaccination can tame flu illness from wild to mild by showing a wild animal, like a tiger, juxtaposed against a more domesticated animal or toy like a kitten. Other examples include a bear with a teddy bear and a shark with a goldfish.”

Sources

  1. Stone, Will. Trump Administration Yanks CDC Flu Vaccine Campaign. NPR. February 20, 2025. https://www.npr.org/sections/shots-health-news/2025/02/19/nx-s1-5302906/cdc-flu-vaccine-campaign-terminated
  2. New Wild to Mild Campaign Drives Key Message to Tame Flu and Reset Expectations. CDC. September 22, 2023. Accessed February 21, 2025. https://www.cdc.gov/flu/whats-new/2023-2024-new-campaign-wild-to-mild.html
Recent Videos
Ted Sweetser
Ted Sweetser
Ted Sweetser
Amy Hessels, Bayer
Related Content

Christopher Wooden

The Promise of Agentic AI to Cut Through HCP Marketing Overwhelm

Christopher Wooden
May 21st 2025
Article

Prioritizing deeper customer insights helps life sciences marketers understand how to engage their HCP audiences effectively with the right message.


Jennifer Butler

The Misinformation Maze: Navigating Public Health in the Digital Age

Miranda Schmalfuhs
March 11th 2025
Podcast

Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.


Abbott

Abbott Launches Health-Focused Soccer Program with Real Madrid

Mike Hollan
May 8th 2025
Article

The program will send 11 young soccer players to learn from professional soccer coaches in Madrid.


Navigating Distrust: Pharma in the Age of Social Media

Navigating Distrust: Pharma in the Age of Social Media

Miranda Schmalfuhs
February 18th 2025
Podcast

Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.


Carnie Wilson

Carnie Wilson Teams with Neurocrine Biosciences for TD Awareness Campaign

Mike Hollan
May 7th 2025
Article

ConnectING with Carnie promotes the importance of routine screening and treatment options for the involuntary movement condition.


Stock.adobe.com

Sanofi to Fly Meningitis Flag on McLaren Car at 24 Hours of Le Mans

Mike Hollan
May 5th 2025
Article

The company is partnering with McLaren Racing and United Autosports for the event.

Related Content

Christopher Wooden

The Promise of Agentic AI to Cut Through HCP Marketing Overwhelm

Christopher Wooden
May 21st 2025
Article

Prioritizing deeper customer insights helps life sciences marketers understand how to engage their HCP audiences effectively with the right message.


Jennifer Butler

The Misinformation Maze: Navigating Public Health in the Digital Age

Miranda Schmalfuhs
March 11th 2025
Podcast

Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.


Abbott

Abbott Launches Health-Focused Soccer Program with Real Madrid

Mike Hollan
May 8th 2025
Article

The program will send 11 young soccer players to learn from professional soccer coaches in Madrid.


Navigating Distrust: Pharma in the Age of Social Media

Navigating Distrust: Pharma in the Age of Social Media

Miranda Schmalfuhs
February 18th 2025
Podcast

Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.


Carnie Wilson

Carnie Wilson Teams with Neurocrine Biosciences for TD Awareness Campaign

Mike Hollan
May 7th 2025
Article

ConnectING with Carnie promotes the importance of routine screening and treatment options for the involuntary movement condition.


Stock.adobe.com

Sanofi to Fly Meningitis Flag on McLaren Car at 24 Hours of Le Mans

Mike Hollan
May 5th 2025
Article

The company is partnering with McLaren Racing and United Autosports for the event.

About
Advertise
Contact Us
Editorial Board
Editorial Submission Guidelines
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.